Evidence map›Paper›PMID 28553104›Full record

ArticleInternational journal of nanomedicine2017

Nanoporosity improved water absorption, in vitro degradability, mineralization, osteoblast responses and drug release of poly(butylene succinate)-based composite scaffolds containing nanoporous magnesium silicate compared with magnesium silicate.

Zhaoying Wu, Quan Li, Yongkang Pan, Yuan Yao, Songchao Tang, Jiacan Su, Jung-Woog Shin, Jie Wei, Jun Zhao

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. PCL/Graphene Scaffolds for the Osteogenesis Process.Bioengineering (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Annals of translational medicine · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Zhaoying WuKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology.
Quan LiDepartment of Orthopaedics Trauma, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Yongkang PanKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology.
Yuan YaoKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology.
Songchao TangKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology.
Jiacan SuDepartment of Orthopaedics Trauma, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Jung-Woog ShinDepartment of Biomedical Engineering, Inje University, Gimhae, Republic of Korea.
Jie WeiKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology.
Jun ZhaoDepartment of Orthodontics.
East China University of Science and Technology · CNSecond Military Medical University · CNInje University · KRShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioactive composite macroporous scaffold containing nanoporosity was prepared by incorporation of nanoporous magnesium silicate (NMS) into poly(butylene succinate) (PBSu) using solvent casting-particulate leaching method. The results showed that the water absorption and in vitro degradability of NMS/PBSu composite (NMPC) scaffold significantly improved compared with magnesium silicate (MS)/PBSu composite (MPC) scaffold. In addition, the NMPC scaffold showed improved apatite mineralization ability, indicating better bioactivity, as the NMPC containing nanoporosity could induce more apatite and homogeneous apatite layer on the surfaces than MPC scaffold. The attachment and proliferation of MC3T3-E1 cells on NMPC scaffold increased significantly compared with MPC scaffold, and the alkaline phosphatase (ALP) activity of the cells on NMPC scaffold was expressed at considerably higher levels compared with MPC scaffold. Moreover, NMPC scaffold with nanoporosity not only had large drug loading (vancomycin) but also exhibited drug sustained release. The results suggested that the incorporation of NMS into PBSu could produce bioactive composite scaffold with nanoporosity, which could enhance water absorption, degradability, apatite mineralization and drug sustained release and promote cell responses.

Indexed as

Tissue ScaffoldsAlkaline PhosphataseAnimalsApatitesBiocompatible MaterialsButylene GlycolsCell LineCell ProliferationDrug LiberationMagnesium SilicatesMiceNanoporesNanostructuresOsteoblastsPolymersVancomycinAlkaline PhosphataseApatitesBiocompatible MaterialsbionoleButylene GlycolsMagnesium SilicatesPolymersVancomycinWaterapatite mineralizationcell behaviorsdegradabilitydrug releasenanocomposite

Identifiers

PMID28553104
PMCPMC5439988
OpenAlexW2613270284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.